During the Parker Heath Lecture at the American Academy of Ophthalmology (AAO) annual meeting, James Madara, MD, CEO of the American Medical Association (AMA), will discuss the 3 arcs of the AMA’s strategic framework and the innovation that needs to occur.
During the Parker Heath Lecture at the American Academy of Ophthalmology (AAO) annual meeting, James Madara, MD, CEO of the American Medical Association (AMA), will discuss the 3 arcs of the AMA’s strategic framework and the innovation that needs to occur.
Transcript
Can you give a preview of what you'll discuss during the Parker Heath Lecture at the AAO annual meeting?
I will discuss a couple of things. One is the strategic framework of the AMA, and it has 3 arcs. Those arcs represent what I would call precompetitive positions. One is chronic disease, one is lifelong learning, and one is removing obstacles from physician-patient interactions. And when you think about that, in the terms of precompetitive, the reason it’s precompetitive is that it doesn't really matter what health system we have, in the mid-century, if we don't have the workforce trained for the 21st century, if we haven't dealt with the problem of chronic disease that’s growing—it's now more than 90% of our $4 trillion health care spend and growing—and if we haven't removed the obstacles so that physicians can better interact with patients, none of those potential health systems would work very well in the mid-21st century. So, in that sense, these are precompetitive needs.
The second point I'll make is that a lot of innovation has to occur under these 3 arcs. Some of that innovation is done internally, some of it is that our venture company formation in Silicon Valley, Health2047. What unites all the work done here and there is that the problem definition has to be at the right site. Too often, the tools and services we have in health care have a starting problem definition at the administrative level. Then the solution is thrown over the transom into the clinic, and we get a series of point solutions that don't interact very well. We need to define a problem where we think the truth of the health system is, and that's between the patient and the physician.
I hope to make those points, and obviously they all require partnering, because these are big problems larger than any one organization can solve.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
AXS25: Health Policy, Drug Costs, and AI Highlights From the Conference
May 6th 2025Asembia’s AXS25 Summit covered a variety of relevant topics in the pharmaceutical industry, from the effects of the new administration to how artificial intelligence (AI) is reshaping the patience experience.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More